Mehran Makvandi
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
- Oncology 21
- PARP inhibition in cancer therapy 20
-
- Neuroblastoma Research and Treatments 7
- Co-authors
- Robert H. Mach (29 shared papers)Kuiying Xu (12 shared papers)Daniel A. Pryma (14 shared papers)Chi-Chang Weng (8 shared papers)Chenbo Zeng (7 shared papers)Sean W. Reilly (6 shared papers)Roshan K. Dhungana (1 shared paper)Gary A. Molander (1 shared paper)
- Journals
- Nuclear Medicine and Biology (5 papers)Journal of Nuclear Medicine (4 papers)Biochemical and Biophysical Research Communications (3 papers)Clinical Cancer Research (3 papers)Journal of the American Chemical Society (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Mehran Makvandi
41 papers receiving 1.5k citations
Mehran Makvandi's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 606
- Radiology, Nuclear Medicine and Imaging 417
- Pharmaceutical Science 80
- Structural Biology 19
- Reproductive Medicine 75
Countries citing papers authored by Mehran Makvandi
This map shows the geographic impact of Mehran Makvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehran Makvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehran Makvandi more than expected).
Fields of papers citing papers by Mehran Makvandi
This network shows the impact of papers produced by Mehran Makvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehran Makvandi. The network helps show where Mehran Makvandi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mehran Makvandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Photochemical Intermolecular [3σ + 2σ]-Cycloaddition for the Construction of Aminobicyclo[3.1.1]heptanes Hit paper breakdown → | 2022 | 214 |
| 2 | 2018 | 148 | |
| 3 | 2018 | 115 | |
| 4 | 2018 | 112 | |
| 5 | 2016 | 88 | |
| 6 | 2018 | 83 | |
| 7 | 2017 | 57 | |
| 8 | 2016 | 56 | |
| 9 | [(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer. | 2016 | 53 |
| 10 | 2019 | 45 | |
| 11 | 2019 | 44 | |
| 12 | 2018 | 41 | |
| 13 | 2021 | 35 | |
| 14 | 2016 | 31 | |
| 15 | 2019 | 31 | |
| 16 | 2019 | 28 | |
| 17 | 2013 | 26 | |
| 18 | 2019 | 26 | |
| 19 | 2020 | 26 | |
| 20 | 2021 | 25 |
About Mehran Makvandi
Mehran Makvandi is a scholar working on Oncology, Neurology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (20 papers), DNA Repair Mechanisms (9 papers), Neuroblastoma Research and Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Pharmacological Receptor Mechanisms and Effects (6 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Oncology (606 citations), Radiology, Nuclear Medicine and Imaging (417 citations), Pharmaceutical Science (80 citations), Structural Biology (19 citations) and Reproductive Medicine (75 citations). Mehran Makvandi has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Robert H. Mach, Kuiying Xu, Daniel A. Pryma, Chi-Chang Weng, Chenbo Zeng, Sean W. Reilly, Roshan K. Dhungana, Gary A. Molander, Sebastian Keeß and Yongxiang Zheng. Their work appears in journals such as Nuclear Medicine and Biology, Journal of Nuclear Medicine, Biochemical and Biophysical Research Communications, Clinical Cancer Research and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.